Skip to main content

Inside the Allure of a Genomics ETF

The Global X Genomics & Biotechnology ETF (Nasdaq: GNOM) is just over four months old, and after slumping for a bit, the fund has surged more than 10% off its June lows as investors embrace new ways of accessing genomics investments. GNOM tracks the Solactive Genomics Index and “seeks to invest...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.